Relay Therapeutics Inc. logo

Relay Therapeutics Inc.

RLAY | NASDAQ
Chart Builder DCF Calculator
$18.55
+$0.36 (+1.98%)
Sep 22, 2026, 11:21 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-276.48M -337.71M -341.97M -290.51M -363.87M -52.41M
Depreciation & Amortization
-1.39M 5.46M 5.27M 4.13M 3.93M 3.55M
Stock-Based Compensation
62.42M 94.14M 86.03M 56.14M 48.45M 31.96M
Other Working Capital
-11.87M 14.62M -35.28M 9.16M 18.62M 571K
Other Non-Cash Items
3.3M -25.62M -17.19M -10.5M 139.74M -416K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-23.31M 14.62M -32.46M 11.25M 97.34M -85.17M
Operating Cash Flow
-235.46M -249.11M -300.32M -229.49M -74.41M -102.49M
Capital Expenditures
-410K -2.02M -4.13M -9.06M -3.47M -1.93M
Cash Acquisitions
n/a n/a n/a 179.68M -25.3M -83.6M
Purchase of Investments
-122.97M -650.63M -385.54M -535.42M -980.67M -266.46M
Sales Maturities Of Investments
316.18M 611.56M 647.3M 355.74M 529.92M 350.06M
Other Investing Acitivies
n/a n/a n/a -179.68M n/a 83.6M
Investing Cash Flow
192.8M -41.08M 257.63M -188.75M -479.51M 81.67M
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 4.26M 4.47M 5.17M 5.88M 1.22M
Financial Cash Flow
1.6M 270.15M 34.75M 289.91M 388.09M 426.51M
Net Cash Flow
-41.05M -20.04M -7.93M -128.33M -165.83M 405.69M
Free Cash Flow
-235.87M -251.13M -304.44M -238.55M -77.88M -104.42M
Adj. Free Cash Flow
-298.28M -345.26M -390.47M -294.69M -126.33M -136.38M
Maintenance CapEx
n/a -2.02M n/a -9.06M -3.47M n/a
Growth CapEx
-410K n/a -4.13M n/a n/a -1.93M
Owner Earnings
-235.46M -251.13M -300.32M -238.55M -77.88M -102.49M

© 2026 bestshares.com. All rights reserved.